Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

117.65 -0.95 (-0.80%)
Official Closing Price Updated: 4:10 PM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
40 41 Next >
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Latch, Azure, Abbott, and TuSimple and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For October 26, 2022
Upgrades 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  Thursday saw 177 companies set new 52-week lows. 
Via Benzinga
Why Abbott Laboratories Stock Is Slumping Today
A potential drop-off in COVID-19 testing sales is weighing on the healthcare giant's shares today. 
Via The Motley Fool
Abbott Laboratories (ABT) Q3 2022 Earnings Call Transcript
ABT earnings call for the period ending September 30, 2022. 
Via The Motley Fool
Abbott Labs Reports Narrower-Than-Expected Quarterly Declines, And Shares Topple
The company's third-quarter results came in well ahead of expectations. 
Via Investor's Business Daily
ABT FINAL DEADLINE: ROSEN, A TOP RANKED FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important October 31 Deadline in Securities Class Action - ABT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Is Abbott Laboratories Still a Good Dividend Stock to Buy?
Third-quarter results were less than encouraging on the surface, but what do they say about the road ahead for Abbott Laboratories? 
Via The Motley Fool
10 Dividend Kings That May Last Centuries
The following 10 Dividend Kings have increased their dividends for at least 50 consecutive years, and stand a good chance of increasing their dividends for another 50 years. 
Via Talk Markets
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Humanigen, Latch, Azure, and Abbott and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Infant Formula Fiasco Weighs On Abbott's Q3 Earnings, Still It Raised FY22 EPS Guidance
Via Benzinga
Amazon To $175? Plus JP Morgan Cuts Price Target On Meta Platforms
JP Morgan cut the price target on Amazon.com, Inc. (NASDAQ: AMZN) from $185 to $175. Amazon shares gained 2.2% to trade at $117.82 on Friday. 
Via Benzinga
Market Rallies, Hits Resistance As Treasury Yields Soar; Tesla, Netflix Are Big Movers: Weekly Review
Tesla hit lows on earnings while Netflix jumped. 
Via Investor's Business Daily
Want Passive Income? 3 Dividend Kings to Buy Right Now
These companies have what it takes to offer earnings growth over time. 
Via The Motley Fool
Bonds And Stocks Slide While Stock Earnings Split
The big headline of today was bonds including TLT and IEF extending their downward slide to fresh new lows of 2022. 
Via Talk Markets
Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade
When saving for retirement, it's important to think beyond near-term market troubles. 
Via The Motley Fool
Why Olaplex Shares Dipped Around 57%; Here Are 75 Biggest Movers From Yesterday
Gainers Amprius Technologies, Inc. (NYSE: AMPX) jumped 77.3% to settle at $11.01 on Wednesday after the company announced it was awarded a $50 million cost-sharing grant from the U.S. Department of... 
Via Benzinga
3 Stocks Set to Soar From 52-Week Lows
Calling a market bottom is nearly impossible and it isn't likely near but these stocks to buy should be shielded from further declines. 
Via InvestorPlace
ABT INVESTOR NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Abbott Laboratories Investors to Secure Counsel Before Important October 31 Deadline in Securities Class Action - ABT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Abbott Laboratories, M&T Bank And Some Other Big Stocks Moving Lower On Wednesday
U.S. stocks traded higher, with the Dow Jones gaining more than 100 points on Wednesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Why United Airlines Shares Are Trading Higher? Here Are 43 Stocks Moving In Wednesday's Mid-Day Session
Gainers SenesTech, Inc. (NASDAQ: SNES) shares jumped 102.6% to $0.47 after declining over 3% on Tuesday. SenesTech, during August, posted a Q2 loss of $0.21 per share. 
Via Benzinga
SpaceX Starlink's New In-Flight Connectivity Service, Amazon's NY Workers Reject Union, Celsius Network Faces Several Federal Investigations: Top Stories Wednesday, Oct. 19
Reuters US Lawmakers Plan Hearing On Kroger, Albertsons' $25B Merger 
Via Benzinga
Abbott Laboratories: Q3 Earnings Insights
Abbott Laboratories (NYSE:ABT) reported its Q3 earnings results on Wednesday, October 19, 2022 at 07:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Ready to Buy the Dip? This Healthcare Stock Is a Smart Buy
DexCom's latest products could drive lasting growth. 
Via The Motley Fool
Earnings Scheduled For October 19, 2022
Companies Reporting Before The Bell • ASML Holding (NASDAQ:ASML) is estimated to report quarterly earnings at $4.01 per share on revenue of $5.93 billion. 
Via Benzinga
Tesla, Procter & Gamble And 3 Stocks To Watch Heading Into Wednesday
With US stock futures trading mixed this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Does J&J Have Enough Alpha to Be a Solid Low Beta Stock?
JNJ stock is seen as a defensive play which has typically done well in bear markets. But there is one issue that makes longer-term forecasts uncertain 
Via MarketBeat
Topics Economy
Exposures Economy
Check Out What Whales Are Doing With ABT
Someone with a lot of money to spend has taken a bullish stance on Abbott Laboratories (NYSE:ABT). And retail traders should know. We noticed this today when the big position showed up on publicly... 
Via Benzinga
Earnings Preview For Abbott Laboratories
Abbott Laboratories (NYSE:ABT) is set to give its latest quarterly earnings report on Wednesday, 2022-10-19. Here's what investors need to know before the announcement. Analysts estimate that Abbott... 
Via Benzinga
< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
40 41 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.